Safety and efficacy of simultaneous bilateral 25-gauge lens-sparing vitrectomy for vascularly active stage 4 retinopathy of prematurity.

Abstract

PURPOSE:

To report the safety and efficacy of simultaneous bilateral 25-gauge lens-sparing vitrectomy for vascularly active stage 4 retinopathy of prematurity (ROP).

METHODS:

Retrospective, noncomparative, consecutive case series. Twenty eyes of 10 babies who presented with vascularly active stage 4 ROP in both the eyes underwent simultaneous bilateral 25-gauge lens-sparing vitrectomy. After completing surgery for one eye, the other eye was re-prepped as performed before starting any new case of a different patient and an entire new set of disposable 25-gauge instruments were used. During the post-operative period parents were advised to keep separate eye drops for each eye and to wash their hands in between switching the eyes to put the drops.

RESULTS:

The mean follow-up was 8.7 months (range 4-17 months). None of the cases developed any signs of infection. The anatomic success rate for stage 4a was 100% (11/11 eyes) and for stage 4b was 8/9 eyes (89%).

CONCLUSION:

These results show that simultaneous bilateral 25-gauge lens-sparing vitrectomy for stage 4 ROP is a safe and effective procedure with a good outcome provided both eyes of the baby are treated as eyes of two different patients.

• Authors: P K Shah, V Narendran, N Kalpana
• Journal: Eye (London, England) (Eye (Lond)) Vol. 29 Issue 8 Pg. 1046-50 (Aug 2015) ISSN: 1476-5454 [Electronic] England
• PMID: 25998945 (Publication Type: Clinical Study, Journal Article)

Topics

• Female
• Follow-Up Studies
• Gestational Age
• Humans
• Infant
• Infant, Newborn
• Infant, Premature
• Lens, Crystalline (surgery)
• Male
• Organ Sparing Treatments (adverse effects, methods)
• Retinal Detachment (surgery)
• Retinopathy of Prematurity (surgery)
• Retrospective Studies
• Visual Acuity
• Vitrectomy (adverse effects, methods)